vs
Side-by-side financial comparison of DoubleDown Interactive Co., Ltd. (DDI) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $83.0M, roughly 1.9× DoubleDown Interactive Co., Ltd.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 30.2%, a 41.0% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 13.7%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $31.6M).
Take-Two Interactive Software, Inc. is an American video game holding company based in New York City founded by Ryan Brant in September 1993.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
DDI vs STOK — Head-to-Head
Income Statement — Q3 FY2024 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.0M | $158.6M |
| Net Profit | $25.0M | $112.9M |
| Gross Margin | 70.1% | — |
| Operating Margin | 42.5% | 70.2% |
| Net Margin | 30.2% | 71.2% |
| Revenue YoY | 13.7% | 3661.1% |
| Net Profit YoY | -7.0% | 528.0% |
| EPS (diluted) | $10.11 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 25 | — | $158.6M | ||
| Q4 24 | — | $22.6M | ||
| Q3 24 | $83.0M | — | ||
| Q2 24 | $88.2M | — | ||
| Q1 24 | $88.1M | — | ||
| Q3 23 | $73.0M | — | ||
| Q2 23 | $75.2M | $-2.5M | ||
| Q1 23 | $77.6M | — |
| Q1 25 | — | $112.9M | ||
| Q4 24 | — | $-10.5M | ||
| Q3 24 | $25.0M | — | ||
| Q2 24 | $33.2M | — | ||
| Q1 24 | $30.3M | — | ||
| Q3 23 | $26.9M | — | ||
| Q2 23 | $24.4M | $-30.7M | ||
| Q1 23 | $23.7M | — |
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 70.1% | — | ||
| Q2 24 | 69.6% | — | ||
| Q1 24 | 68.9% | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
| Q1 25 | — | 70.2% | ||
| Q4 24 | — | -60.4% | ||
| Q3 24 | 42.5% | — | ||
| Q2 24 | 41.0% | — | ||
| Q1 24 | 35.2% | — | ||
| Q3 23 | 40.7% | — | ||
| Q2 23 | 36.6% | 1340.7% | ||
| Q1 23 | 32.7% | — |
| Q1 25 | — | 71.2% | ||
| Q4 24 | — | -46.4% | ||
| Q3 24 | 30.2% | — | ||
| Q2 24 | 37.6% | — | ||
| Q1 24 | 34.4% | — | ||
| Q3 23 | 36.9% | — | ||
| Q2 23 | 32.4% | 1235.6% | ||
| Q1 23 | 30.5% | — |
| Q1 25 | — | $1.90 | ||
| Q4 24 | — | $-0.15 | ||
| Q3 24 | $10.11 | — | ||
| Q2 24 | $13.39 | — | ||
| Q1 24 | $12.23 | — | ||
| Q3 23 | $10.87 | — | ||
| Q2 23 | $9.83 | $-0.69 | ||
| Q1 23 | $9.55 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $372.7M | $274.8M |
| Total DebtLower is stronger | $37.9M | — |
| Stockholders' EquityBook value | $815.5M | $350.1M |
| Total Assets | $879.8M | $406.9M |
| Debt / EquityLower = less leverage | 0.05× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 25 | — | $274.8M | ||
| Q4 24 | — | $128.0M | ||
| Q3 24 | $372.7M | — | ||
| Q2 24 | $339.2M | — | ||
| Q1 24 | $309.5M | — | ||
| Q3 23 | $271.2M | — | ||
| Q2 23 | $245.1M | $192.1M | ||
| Q1 23 | $304.8M | — |
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $37.9M | — | ||
| Q2 24 | $36.0M | — | ||
| Q1 24 | $37.1M | — | ||
| Q3 23 | $37.2M | — | ||
| Q2 23 | $38.1M | — | ||
| Q1 23 | $38.3M | — |
| Q1 25 | — | $350.1M | ||
| Q4 24 | — | $229.0M | ||
| Q3 24 | $815.5M | — | ||
| Q2 24 | $786.2M | — | ||
| Q1 24 | $755.2M | — | ||
| Q3 23 | $697.9M | — | ||
| Q2 23 | $672.8M | $190.2M | ||
| Q1 23 | $648.6M | — |
| Q1 25 | — | $406.9M | ||
| Q4 24 | — | $271.6M | ||
| Q3 24 | $879.8M | — | ||
| Q2 24 | $852.6M | — | ||
| Q1 24 | $831.0M | — | ||
| Q3 23 | $760.6M | — | ||
| Q2 23 | $740.7M | $256.9M | ||
| Q1 23 | $811.3M | — |
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.05× | — | ||
| Q1 24 | 0.05× | — | ||
| Q3 23 | 0.05× | — | ||
| Q2 23 | 0.06× | — | ||
| Q1 23 | 0.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $31.8M | $131.8M |
| Free Cash FlowOCF − Capex | $31.6M | $131.7M |
| FCF MarginFCF / Revenue | 38.0% | 83.0% |
| Capex IntensityCapex / Revenue | 0.3% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.27× | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $129.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 25 | — | $131.8M | ||
| Q4 24 | — | $-23.2M | ||
| Q3 24 | $31.8M | — | ||
| Q2 24 | $34.4M | — | ||
| Q1 24 | $34.9M | — | ||
| Q3 23 | $28.7M | — | ||
| Q2 23 | $-56.8M | $-21.8M | ||
| Q1 23 | $19.2M | — |
| Q1 25 | — | $131.7M | ||
| Q4 24 | — | $-23.2M | ||
| Q3 24 | $31.6M | — | ||
| Q2 24 | $34.4M | — | ||
| Q1 24 | $34.9M | — | ||
| Q3 23 | $28.7M | — | ||
| Q2 23 | $-56.9M | $-22.6M | ||
| Q1 23 | $19.2M | — |
| Q1 25 | — | 83.0% | ||
| Q4 24 | — | -102.7% | ||
| Q3 24 | 38.0% | — | ||
| Q2 24 | 39.0% | — | ||
| Q1 24 | 39.6% | — | ||
| Q3 23 | 39.3% | — | ||
| Q2 23 | -75.7% | 912.5% | ||
| Q1 23 | 24.7% | — |
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — | ||
| Q3 23 | 0.1% | — | ||
| Q2 23 | 0.1% | -33.8% | ||
| Q1 23 | 0.1% | — |
| Q1 25 | — | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | 1.04× | — | ||
| Q1 24 | 1.15× | — | ||
| Q3 23 | 1.07× | — | ||
| Q2 23 | -2.33× | — | ||
| Q1 23 | 0.81× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
